<DOC>
	<DOCNO>NCT02041546</DOCNO>
	<brief_summary>Meconium aspiration syndrome ( MAS ) important cause severe respiratory failure newborn infant . Treatment MAS mainly supportive surfactant therapy might change course disease . Aim study evaluate whether lung lavage dilute bolus poractant alfa change duration mechanical respiratory support outcomes MAS .</brief_summary>
	<brief_title>Lung Lavage With Dilute Poractant Alfa Meconium Aspiration Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Meconium Aspiration Syndrome</mesh_term>
	<mesh_term>Poractant alfa</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>Infants gestational age ≥ 36 week , birth weight ≥ 2.0 kg , evidence passage meconium delivery , typical chest radiology finding mechanically ventilate infant mean airway pressure ≥ 12 cm H2O enrol . Congenital cardiac anomaly Major congenital anomaly Hemodynamically unstable infant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Lung lavage ,</keyword>
	<keyword>Surfactant ,</keyword>
	<keyword>Duration mechanical</keyword>
	<keyword>ventilation</keyword>
</DOC>